Bedoukian   RussellIPM   RussellIPM   Piezoelectric Micro-Sprayer


Home
Animal Taxa
Plant Taxa
Semiochemicals
Floral Compounds
Semiochemical Detail
Semiochemicals & Taxa
Synthesis
Control
Invasive spp.
References

Abstract

Guide

Alphascents
Pherobio
InsectScience
E-Econex
Counterpart-Semiochemicals
Print
Email to a Friend
Kindly Donate for The Pherobase

« Previous AbstractPreparation and characterization of novel mesoporous ceria-titania    Next AbstractTheoretical aspects of sex odor in swine »

JHEP Rep


Title:Volatomic analysis identifies compounds that can stratify non-alcoholic fatty liver disease
Author(s):Sinha R; Lockman KA; Homer NZM; Bower E; Brinkman P; Knobel HH; Fallowfield JA; Jaap AJ; Hayes PC; Plevris JN;
Address:"Hepatology Laboratory and Centre for Liver and Digestive Disorders, Royal Infirmary of Edinburgh and The University of Edinburgh, Edinburgh, UK. Edinburgh Acute & General Medicine, Royal Infirmary of Edinburgh and The University of Edinburgh, Edinburgh, UK. Mass Spectrometry Core, Edinburgh Clinical Research Facility, Centre for Cardiovascular Science, The University of Edinburgh, Edinburgh, UK. Department of Respiratory Medicine, Amsterdam University Medical Centre, Amsterdam, The Netherlands. Eurofins Materials Science Netherlands BV, High Tech Campus, Eindhoven, The Netherlands. Centre for Inflammation Research, The University of Edinburgh, Edinburgh, UK. Edinburgh Centre for Endocrinology and Diabetes, Royal Infirmary of Edinburgh and The University of Edinburgh, Edinburgh, UK"
Journal Title:JHEP Rep
Year:2020
Volume:20200615
Issue:5
Page Number:100137 -
DOI: 10.1016/j.jhepr.2020.100137
ISSN/ISBN:2589-5559 (Electronic) 2589-5559 (Linking)
Abstract:"BACKGROUND & AIMS: Analysis of volatile organic compounds (VOCs) in exhaled breath, 'volatomics', provides opportunities for non-invasive biomarker discovery and novel mechanistic insights into a variety of diseases. The purpose of this pilot study was to compare breath VOCs in an initial cohort of patients with non-alcoholic fatty liver disease (NAFLD) and healthy controls. METHODS: Breath samples were collected from 15 participants with Child-Pugh class A NAFLD cirrhosis, 14 with non-cirrhotic NAFLD, and 14 healthy volunteers. Exhaled breath samples were collected using an established methodology and VOC profiles were analysed by gas chromatography-mass spectrometry. The levels of 19 VOCs previously associated with cirrhosis were assessed. Peaks of the VOCs were confirmed and integrated using Xcalibur(R) software, normalised to an internal standard. Receiver-operating characteristic (ROC) curves were used to determine the diagnostic accuracy of the candidate VOCs. RESULTS: Terpinene, dimethyl sulfide, and D-limonene provided the highest predictive accuracy to discriminate between study groups. Combining dimethyl sulfide with D-limonene led to even better discrimination of patients with NAFLD cirrhosis from healthy volunteers (AUROC 0.98; 95% CI 0.93-1.00; p <0.001) and patients with NAFLD cirrhosis from those with non-cirrhotic NAFLD (AUROC 0.91; 95% CI 0.82-1.00; p <0.001). Breath terpinene concentrations discriminated between patients with non-cirrhotic NAFLD and healthy volunteers (AUROC 0.84; 95% CI 0.68-0.99; p = 0.002). CONCLUSION: Breath terpinene, dimethyl sulfide, and D-limonene are potentially useful volatomic markers for stratifying NAFLD; in addition, a 2-stage approach enables the differentiation of patients with cirrhosis from those without. However, these observations require validation in a larger NAFLD population. (ClinicalTrials.gov Identifier: NCT02950610). LAY SUMMARY: Breath malodour has been associated with a failing liver since the ancient Greeks. Analytical chemistry has provided us an insight into ubiquitous volatile organic compounds associated with liver (and other) diseases. This has vastly improved our understanding of the mechanistic processes of liver damage. Our study aims to identify volatile organic compounds which are specific to non-alcoholic fatty liver disease and that can be exploited for rapid diagnostics"
Keywords:"ALT, alanine aminotransaminase APRI, aminotransferase:platelet ratio index ARFI, acoustic radiation force impulse AST, aspartate aminotransferase AUROC, area under the receiver-operating characteristics curve BMI, body mass index D-limonene Dimethyl sulfi;"
Notes:"PubMed-not-MEDLINESinha, Rohit Lockman, Khalida A Homer, Natalie Z M Bower, Edward Brinkman, Paul Knobel, Hugo H Fallowfield, Jonathan A Jaap, Alan J Hayes, Peter C Plevris, John N eng Netherlands 2020/08/11 JHEP Rep. 2020 Jun 15; 2(5):100137. doi: 10.1016/j.jhepr.2020.100137. eCollection 2020 Oct"

 
Back to top
 
Citation: El-Sayed AM 2024. The Pherobase: Database of Pheromones and Semiochemicals. <http://www.pherobase.com>.
© 2003-2024 The Pherobase - Extensive Database of Pheromones and Semiochemicals. Ashraf M. El-Sayed.
Page created on 03-07-2024